Press release
Global Biologics Safety Testing Market Key Players, Size, Share Demands, Trends, Application and Forecasts to 2026
Global Biologics Safety Testing Market was valued at USD 3463.90 Million in the year 2020. Major factors driving the growth of this market are the growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science sector, increasing number of drug launches, high incidence and large economic burden of chronic diseases. In the coming years, emerging markets and increasing pharmaceutical outsourcing are expected to offer growth opportunities for players in the biologics safety testing market. The rising need for biologics has resulted in unprecedented growth in the number of biopharmaceutical companies. Increasing competition to develop therapeutically advanced drugs on a large scale has compelled manufacturers to improve aspects of manufacturing processes such as productivity and cost-efficiency.Get Free Sample Copy of this Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=4298842
High kits and reagents accounted for the largest share of the market among product type segment. The growth of high kits and reagents are driven by repeat purchase of kits and reagents as compared to instruments and increasing adoption of kit-based testing. Additionally, Services followed by High kits & reagents and Instruments will also boost the biologics safety testing market in coming years.
Moreover, growth in pharmaceutical and biotechnology industry, tremendous R&D ventures by new players in the life sciences industry, and increment in number of new medications launches in recent years drive the biologics safety testing market. However, stringent government directions for endorsement of biologics and high cost of medication advancement restricts the market development. Likewise, legislative aid towards giving assets to biologics advancement and its safety is predicted to offer lucrative market growth avenues. Growing pharmaceutical and biotechnology industry, rising investments in research and development by key players in the life sciences industry, and rising number of new drugs entering into the market are few factors driving the biologics safety testing market. Regulatory organizations are working towards implementing relevant standards for biological safety to ensure the patient’s safety.
Among the regions, North America accounted for the largest share of the biologics safety testing market in 2020. Factors such as strong R&D trend in life sciences and growth in pharmaceutical industries will drive the biologics safety testing market in the North American region. The dominant share can be attributed to high investments in biotechnology, increased adoption in cancer research, and the development of new biologics, vaccines, & drugs.
Get 20% Discount on this Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=4298842
Scope of the Report
- The report analyses Biologics Safety Testing Market by Value.
- The report analyses Biologics Safety Testing Market Product Type (High Kits & Reagents, Instruments, Services).
- The report further assesses the Biologics Safety Testing Market by Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others).
- The report further assesses the Biologics Safety Testing Market by Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests and Others)
- The Global Nucleic Acid Isolation and Purification Market has been analysed By Region (North America, Europe, Asia Pacific and ROW) and By Country (United States, Canada, Germany, France, U.K, Italy, China, Japan, India and South Korea).
- The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions, Technological Innovations, and Role of Manufacturers during COVID Pandemic. Also, the attractiveness of the market has been presented By Region, By Product, By Application, and By Test. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The companies analysed in the report include Lonza Group Ltd., SGS S.A., Sartorious AG, Merck KGaA, Thermo Fisher Scientific Inc, Samsung Biologics, Charles River Laboratories International Inc., Maravai life sciences, Wuxi APPTEC, Eurofins Scientific.
- The report presents the analysis of Biologics Safety Testing Market for the historical period of 2016-2020 and the forecast period of 2021-2026.
Key Target Audience
- Biologics Safety Testing suppliers
- Hospitals and healthcare units
- Consulting and Advisory Firms
- Investment Banks and Equity Firms
Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=4298842
Table of Contents:
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Biologics Safety Testing Market: Product Overview
4. Global Biologics Safety Testing Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2016-2026
4.2 Impact of COVID-19 on Biologics Safety Testing Market
5. Global Biologics Safety Testing Market; An Analysis (2021-2026)
5.1 Competitive Scenario of Global Biologics Safety Testing Market: By Product
5.1.1 High Kits & Reagents ñ Market Size and Forecast (2016-2026)
5.1.2 Instruments - Market Size and Forecast (2016-2026)
5.1.3 Services ñ Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Biologics Safety Testing Market: By Application
5.2.1 Vaccine & Therapeutics ñ Market Size and Forecast (2016-2026)
5.2.2 Blood & Blood Based Products ñ Market Size and Forecast (2016-2026)
5.2.3 Gene Therapy - Market Size and Forecast (2016-2026)
5.2.4 Others ñ Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Biologics safety testing Market: By Test
5.3.1 Endotoxin Tests - Market Size and Forecast (2016-2026)
5.3.2 Sterility Tests - Market Size and Forecast (2016-2026)
5.3.3 Bioburde Tests ñ-Market Size and Forecast (2016-2026)
5.3.4 Adventitious Agent Detection Tests ñ Market Size and Forecast (2016-2026)
5.3.5 Others ñ Market Size and Forecast (2016-2026)
6. Global Biologics safety testing Market: Regional Analysis
6.1 Competitive Scenario of Global Biologics safety testing Market: By Region
7. North America Biologics safety testing Market: An Analysis (2021-2026)
7.1 North America Biologics safety testing Market : Size and Forecast (2016-2026), By Value
7.2 North America Biologics safety testing Market ñ Prominent Companies
7.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)
7.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others)
7.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburde Tests, Adventitious Agent Detection Tests and Others)
7.6 North America Biologics safety testing Market: Country Analysis
7.7 Market Opportunity Chart of North America Biologics safety testing Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Biologics safety testing Market : By Country
7.9 United States Biologics safety testing Market: Size and Forecast (2016-2026), By Value
7.10 United States Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
7.11 Canada Biologics safety testing Market: Size and Forecast (2016-2026), By Value
7.12 Canada Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8. Europe Biologics safety testing Market: An Analysis (2021-2026)
8.1 Europe Biologics safety testing Market : Size and Forecast (2016-2026), By Value
8.2 Europe Biologics safety testing Market ñ Prominent Companies
8.3 Market Segmentation By Product Type (High Kits & Reagents, Instruments and Services)
8.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy, Others)
8.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests, Others)
8.6 Europe Biologics safety testing Market: Country Analysis
8.7 Market Opportunity Chart of Europe Biologics safety testing Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Biologics safety testing Market : By Country
8.9 Germany Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.10 Germany Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.11 United Kingdom Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.12 United Kingdom Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.13 France Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.14 France Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
8.15 Italy Biologics safety testing Market: Size and Forecast (2016-2026), By Value
8.16 Italy Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9. Asia Pacific Biologics safety testing Market: An Analysis (2021-2026)
9.1 Asia Pacific Biologics safety testing Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Biologics safety testing Market ñ Prominent Companies
9.3 Market Segmentation By Product Type ( High Kits & Reagents, Instruments and Services)
9.4 Market Segmentation By Application Type (Vaccine & Therapeutics, Blood & Blood Based Products, Gene Therapy and Others)
9.5 Market Segmentation By Test (Endotoxin Tests, Sterility Tests, Bioburden Tests, Adventitious Agent Detection Tests and Others)
9.6 Asia Pacific Biologics safety testing Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Biologics safety testing Market - By Country, By Value, 2026
9.8 Competitive Scenario of Asia Pacific Biologics safety testing Market : By Country
9.9 China Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.10 China Medical Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.11 Japan Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.12 Japan Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.13 South Korea Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.14 South Korea Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
9.15 India Biologics safety testing Market: Size and Forecast (2016-2026), By Value
9.16 India Biologics safety testing Market Segmentation - By Product Type, By Application Type and By Test (2016-2026)
10. Global Biologics safety testing Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Biologics safety testing Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Biologics safety testing Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Biologics safety testing Market - By Test, 2026
11.4 Market Attractiveness Chart of Global Biologics safety testing Market - By Region, 2026
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 SWOT Analysis
12.3 Market Share Analysis
13. Regulatory Compliance
14. Company Profiles (Business Description, Financial Analysis, Business Strategy)
14.1 Lonza Group Ltd.,
14.2 SGS S.A.
14.3 Sartorious AG
14.4 Merck KGaA
14.5 Thermo Fisher Scientific Inc.
14.6 Samsung Biologics,
14.7 Charles River Laboratories International Inc.
14.8 Maravai life sciences
14.9 Wuxi APPTEC
14.10 Eurofins Scientific
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
+ 1 888 391 5441
sales@reportsandreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biologics Safety Testing Market Key Players, Size, Share Demands, Trends, Application and Forecasts to 2026 here
News-ID: 2265940 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Biologics
Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report.
the…
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the…
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off)
The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides…
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025.
Get Free Sample Copy of this Research…
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development…
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to…
